Austin Health

Title
Natural History Study of STXBP1-Developmental and Epileptic Encephalopathy Into Adulthood.
Publication Date
2022-07-19
Author(s)
Stamberger, Hannah
Crosiers, David
Balagura, Ganna
Bonardi, Claudia M
Basu, Anna
Cantalupo, Gaetano
Chiesa, Valentina
Christensen, Jakob
Dalla Bernardina, Bernardo
Ellis, Colin A
Furia, Francesca
Gardiner, Fiona
Giron, Camille
Guerrini, Renzo
Klein, Karl Martin
Korff, Christian
Krijtova, Hana
Leffner, Melanie
Lerche, Holger
Lesca, Gaetan
Lewis-Smith, David
Marini, Carla
Marjanovic, Dragan
Mazzola, Laure
McKeown Ruggiero, Sarah
Mochel, Fanny
Ramond, Francis
Reif, Philipp S
Richard-Mornas, Aurélie
Rosenow, Felix
Schropp, Christian
Thomas, Rhys H
Vignoli, Aglaia
Weber, Yvonne
Palmer, Elizabeth
Helbig, Ingo
Scheffer, Ingrid E
Striano, Pasquale
Møller, Rikke S
Gardella, Elena
Weckhuysen, Sarah
Type of document
Journal Article
OrcId
https://orcid.org/0000-0003-0212-8318
https://orcid.org/0000-0002-6266-3665
https://orcid.org/0000-0003-1343-8434
https://orcid.org/0000-0002-9385-6435
https://orcid.org/0000-0002-7272-7079
https://orcid.org/0000-0003-1344-5554
https://orcid.org/0000-0002-1783-8710
https://orcid.org/0000-0002-1735-8178
https://orcid.org/0000-0002-9212-2691
https://orcid.org/0000-0003-4540-8096
https://orcid.org/0000-0002-3989-7471
https://orcid.org/0000-0003-2062-8623
https://orcid.org/0000-0003-4638-4663
https://orcid.org/0000-0003-1844-215X
https://orcid.org/0000-0001-8486-0558
https://orcid.org/0000-0002-2311-2174
https://orcid.org/0000-0002-6065-1476
https://orcid.org/0000-0002-9664-1448
https://orcid.org/0000-0002-7138-6022
https://orcid.org/0000-0003-2878-1147
DOI
10.1212/WNL.0000000000200715
Abstract
Pathogenic STXBP1 variants cause a severe early-onset developmental and epileptic encephalopathy (STXBP1-DEE). We aimed to investigate the natural history of STXBP1-DEE in adults focusing on seizure evolution, the presence of movement disorders, and the level of functional (in)dependence. In this observational study, patients with a minimum age of 18 years carrying a (likely) pathogenic STXBP1 variant were recruited through medical genetics departments and epilepsy centers. Treating clinicians completed clinical questionnaires and performed semistructured video examinations while performing tasks from the (modified) Unified Parkinson Disease Rating Scale when possible. Thirty adult patients were included for summary statistics, with video recordings available for 19 patients. The median age at last follow-up was 24 years (range 18-58 years). All patients had epilepsy, with a median onset age of 3.5 months. At last follow-up, 80% of adults had treatment-resistant seizures despite long periods of seizure freedom in 37%. Tonic-clonic, focal, and tonic seizures were most frequent in adults. Epileptic spasms, an unusual feature beyond infancy, were present in 3 adults. All individuals had developmental impairment. Periods of regression were present in 59% and did not always correlate with flare-ups in seizure activity. Eighty-seven percent had severe or profound intellectual disability, 42% had autistic features, and 65% had significant behavioral problems. Video examinations showed gait disorders in all 12 patients able to walk, including postural abnormalities with external rotation of the feet, broad-based gait, and asymmetric posture/dystonia. Tremor, present in 56%, was predominantly of the intention/action type. Stereotypies were seen in 63%. Functional outcome concerning mobility was variable ranging from independent walking (50%) to wheelchair dependence (39%). Seventy-one percent of adults were nonverbal, and all were dependent on caregivers for most activities of daily living. STXBP1-DEE warrants continuous monitoring for seizures in adult life. Periods of regression are more frequent than previously established and can occur into adulthood. Movement disorders are often present and involve multiple systems. Although functional mobility is variable in adulthood, STXBP1-DEE frequently leads to severe cognitive impairments and a high level of functional dependence. Understanding the natural history of STXBP1-DEE is important for prognostication and will inform future therapeutic trials.
Link
Citation
Neurology 2022; 99(3): e221-e233
Jornal Title
Neurology

Files:

NameSizeformatDescriptionLink